[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
INDICES> Gangliosides marketing in the world
- From: Rogerio Hoefler <hoefler@cff.org.br>
- Date: Tue, 20 Feb 2001 00:11:46 -0500 (EST)
INDICES> Gangliosides marketing in the world
--------------------------------------------
Hello colleagues,
I am looking for worldwide data about gangliosides and
monosyalogangliosides marketing. I know about their withdrawal in Germany,
Greece, Luxembourg, Spain and Portugal (CPMP - Pharmacovigilance Opinion
No.17, Sept. 1994).
These drugs have been marketed in Brazil by TRB Pharma but I'm not sure if they
have been marketing in the countries wich TRB Pharma (or other company) has
representation (Japan, Switzerland, Argentina, Hong Kong, Singapore, Malaysia,
Thailand and Colombia).
In addition, I would like to have any information about the "history" of
these drugs (where these appeared, where they were/are marketed/marketing,
the argument for marketing, etc).
Please, could anyone help me?
Thanks in advance.
Rogério Hoefler
Pharmacist
Brazilian Drug Information Centre - CEBRIM
hoefler@cff.org.br
[anybody willing to support Rogerio? Please send emails directly to him. We will
ask him to summarize the results back to the list. Thanks WB]
--
Send mail for the `INDICES' conference to `indices@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-indices@usa.healthnet.org'.
|